Clinical trial Recruiting at 1 site Interventional Ages 20 and up

Comparing two types of shoulder injections for osteoarthritis pain relief

Official title: A Randomized Single-blinded Clinical Trial of the Efficacy of Intra-articular Infiltration of Cingal (Sodium Hyaluronate/Triamcinolone) Versus Cortisone (Triamcinolone) in Patients With Osteoarthritis of the Shoulder.

Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT05408065 · Data updated 2026-11-12

This study is testing whether a new shoulder injection called Cingal can help people with moderate to severe shoulder osteoarthritis feel less pain compared to a standard cortisone injection.

More Shoulder Osteoarthritis trials

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment84 (estimated)
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedNovember 15, 2022
Main results expectedSeptember 2026
Study endsDecember 2026
Registry record updatedFebruary 12, 2024
Trial IDNCT05408065 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20 to 90 with moderate to severe primary shoulder osteoarthritis and a pain level of at least 4/10.

Probably not a fit

Patients with certain exclusions, such as those with a rotator cuff tear or who have had recent cortisone injections, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the analgesic effects of two different shoulder infiltrations: Cingal, which combines sodium hyaluronate and triamcinolone, and cortisone alone. It will involve 84 patients with moderate to severe shoulder osteoarthritis, who will be randomly assigned to receive one of the two treatments. The study will assess pain relief and functional ability through clinical examinations and patient questionnaires. The goal is to determine if Cingal provides greater pain relief than cortisone in this patient population.

Why it matters

Potential benefit: If successful, this study could offer a more effective pain management option for patients with shoulder osteoarthritis.

How similar studies have gone: While several studies have shown the effectiveness of hyaluronic acid for other joint conditions, the specific comparison of Cingal and cortisone for shoulder osteoarthritis is less explored, making this approach somewhat novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A clinical examination that confirms the radiological diagnosis of moderate to severe primary shoulder osteoarthritis, stage II and above, according to the Samilson-Prieto classification.
* Patients aged between 20 and 90 years.
* A patient with bilateral shoulder osteoarthritis will choose the side of the infiltration, only one side can be chosen to participate in the study.
* The patient must have a clinical pain threshold of a minimum of 4/10 on the visual analogue scale.
* The patient must have the cognitive ability to read and fill out the questionnaires.
* The patient must be able to read and understand French or English

Exclusion Criteria:

* Presence of a transfixing rotator cuff tear assessed on MRI.
* No previous shoulder reconstruction surgery.
* Pregnant woman.
* A patient who has received a cortisone infiltration within 6 months prior to the start of the study.
* A patient who has received a platelet-rich plasma or a hyaluronic acid infiltration within 12 months prior to the start of the study.
* Diagnosis of avascular necrosis.
* Disease affecting the studied joint (systemic inflammatory disease, history of septic arthritis, osteonecrosis, etc.)
* Suspicion or presence of active local infectious process.
* Presence or suspicion of neoplasia or local metastasis.
* Severe trauma to the shoulder ( ≤ 3 months)
* Significant cognitive impairment or insufficient language proficiency to adequately answer the questionnaires.
* Any other serious medical condition that does not allow participation in the study or may be a contraindication to cortisone injection.

Where it's running

  • Centre Hospitalier de l'Université de Montréal (CHUM)
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.